Department of Urology, University of California, San Francisco, San Francisco, California, USA.
Curr Opin Urol. 2018 Jul;28(4):329-335. doi: 10.1097/MOU.0000000000000511.
Qualified clinical data registries (QCDRs) serve as a framework for quality improvement efforts, clinical research endeavors, and participation in reimbursement incentive programs. However, the measurement of quality and the recommendations to guide QCDRs in developing new quality measures is a complex process. In this review, we highlight the government policies that lead to the creation of QCDRs, how QCDR quality measures are developed, and the current QCDRs that focus on urological care.
QCDRs facilitate participation in the merit-based incentive payment system for reimbursement adjustments. Most QCDRs leverage existing clinical guidelines in the development of new quality measures. In 2018, there are four urology QCDRs with quality measures for many urological conditions. These QCDRs form the infrastructure for quality improvement and provide new resources for research endeavors.
Quality measurement within QCDRs will allow urologists to focus improvement efforts to deliver high-quality urological care while also facilitating reimbursement incentives and creating novel research datasets.
合格临床数据注册（QCDR）为质量改进工作、临床研究工作以及参与报销激励计划提供了框架。然而，衡量质量以及为 QCDR 制定新质量措施的建议是一个复杂的过程。在这篇综述中，我们强调了导致 QCDR 创建的政府政策，QCDR 质量措施的制定方式，以及专注于泌尿外科护理的当前 QCDR。
QCDR 促进了参与基于绩效的奖励支付系统以进行报销调整。大多数 QCDR 利用现有的临床指南来制定新的质量措施。2018 年，有四个泌尿外科 QCDR，针对许多泌尿外科疾病制定了质量措施。这些 QCDR 为质量改进提供了基础设施，并为研究工作提供了新的资源。
QCDR 内的质量衡量将使泌尿科医生能够专注于改进工作，提供高质量的泌尿外科护理，同时促进报销激励，并创建新的研究数据集。
